Humira Market to Decline to USD 6.90 Billion by 2032 Amid Intensifying Biosimilar Competition and Patent Expirations

0
1KB

According to a report by Intel Market Research, the global Humira Market was valued at USD 13.12 billion in 2024 and is projected to decline from USD 12.08 billion in 2025 to USD 6.90 billion by 2032, registering a negative CAGR of -9.0% during the forecast period. The market is undergoing a significant transformation following the expiration of key patents and the rapid entry of biosimilar competitors, resulting in increased pricing pressure and substantial market share erosion for the originator product.

Humira (adalimumab), a tumor necrosis factor (TNF) inhibitor developed by AbbVie, has long been one of the world's best-selling biologic therapies. The drug is widely used for the treatment of chronic inflammatory and autoimmune conditions, including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, and plaque psoriasis. Its broad range of approved indications and extensive clinical history have established Humira as a cornerstone therapy across multiple medical specialties.

Download Sample Report: https://www.intelmarketresearch.com/humira-market-market-16317

The market's contraction is primarily driven by the loss of patent exclusivity in major markets, particularly the United States, where multiple biosimilar versions of adalimumab entered the market following patent expiration in 2023. Biosimilar manufacturers are offering lower-cost alternatives, encouraging healthcare providers, insurers, and pharmacy benefit managers to adopt more cost-effective treatment options. As a result, pricing competition has intensified, accelerating the decline in revenue generated by the branded Humira product.

Despite these challenges, demand for adalimumab-based therapies remains strong due to the growing prevalence of chronic inflammatory diseases worldwide. Rising diagnosis rates, expanding healthcare access, and increasing awareness of autoimmune disorders continue to support treatment adoption. Additionally, the availability of lower-cost biosimilars is improving patient access to biologic therapies, particularly in emerging markets where affordability has historically been a barrier.

Manufacturers are focusing on product differentiation strategies, including high-concentration citrate-free formulations, enhanced patient support programs, and improved self-administration devices to retain patient loyalty and maintain market presence. Furthermore, opportunities remain in emerging economies across Asia-Pacific, Latin America, and the Middle East, where expanding healthcare infrastructure and growing demand for advanced biologic treatments are expected to support future market growth.

North America remains the largest regional market due to its high biologic therapy adoption rates, established reimbursement systems, and large patient population. However, Europe continues to lead in biosimilar adoption, creating a highly competitive environment that serves as a model for future market developments worldwide.

Key Players Operating in the Humira Market:

  • AbbVie Inc.
  • Amgen Inc.
  • Boehringer Ingelheim
  • Sandoz International GmbH (Novartis)
  • Coherus BioSciences, Inc.
  • Fresenius Kabi
  • Viatris Inc.
  • Organon & Co.
  • Pfizer Inc.
  • Samsung Bioepis
  • Cadila Healthcare Ltd. (Zydus Cadila)
  • Torrent Pharmaceuticals Ltd.
  • Eisai Co., Ltd.
  • Celltrion Inc.

Download Sample Report: https://www.intelmarketresearch.com/humira-market-market-16317

Get Full Report: https://www.intelmarketresearch.com/humira-market-market-16317

As the global biologics landscape continues to evolve, market participants are expected to focus on competitive pricing strategies, biosimilar expansion, product innovation, and patient-centric solutions to navigate the changing dynamics of the Humira market and capitalize on emerging opportunities worldwide.

🌐 Website: https://www.intelmarketresearch.com

📞 Asia-Pacific: +91 9169164321 🔗

 LinkedIn: Follow Us

 

Search
Nach Verein filtern
Read More
Art
Affordable Embroidery Digitizing Service for Businesses and Creators
Running an embroidery business or creating custom stitched products can be exciting, but it also...
Von David Official 2026-01-27 06:19:42 0 2KB
Film
Viral ~𝐃o𝘄nl𝗞𝚊d Holly Humberstone - Cruel World (zðĒð™Ĩ 2026) {𝘞l𝐛uðĶ mð—―3 ð“ŧ Latest News
ðŸ˜ģ THIS VIDEO IS EVERYWHERE RIGHT NOW ðŸ”Ĩ WATCH FULL VIDEO ðŸšĻ SECRET VIDEO JUST LEAKED ONLINE 👉...
Von Nuhvaj Nuhvaj 2026-08-06 02:32:54 0 589
Other
Context Aware Computing market Industry Trends, Demand Insights and Growth Forecast Report
"Context Aware Computing Market Summary: According to the latest report published by Data Bridge...
Von Yashodhan Alandkar 2026-04-29 07:08:50 0 1KB
Film
Update āļŦāļ™āļąāļ‡xxx āđāļ™āļ§āļ„āļĢāļ­āļšāļ„āļĢāļąāļ§ GVG-971 āļāđˆāļ­āļ™āļˆāļ°āđƒāļŦāđ‰āļĨāļđāļāđ€āļĨāļĩāđ‰āļĒāļ‡āđ€āļĒāđ‡āļ” āđāļĄāđˆāļĄāļēāđ€āļĒāđ‡āļ”āļāļąāļšāļĨāļđāļāļ•āļąāļ§āđ€āļ­āļ‡āļāđˆāļ­āļ™āļ™āļ° āļ„āļ§āļēāļĄāđ€āļ‡āļĩāđˆāļĒāļ™āđ„āļĄāđˆāđ€āļ„āļĒāļ›āļĢāļēāļ“āļĩāđƒāļ„āļĢ āđāļĄāđˆāļĨāļđāļāđ€āļĒāđ‡āļ”āļāļąāļ™āļŠāļļāļ”āđ€āļŠāļĩāļĒāļ§ āđ€āļˆāļ­āļ—āļąāđ‰āļ‡āļāļĢāļ°āđ€āļˆāļĩāđŠāļĒāļ§āļĨāļđāļāđāļ—āđ‰āļĨāļđāļāđ€āļĨāļĩāđ‰āļĒāļ‡āļŦāļĩāđāļ—āļšāđ„āļĄāđˆāđ„āļ”āđ‰āļžāļąāļāļˆāļąāļ”āļŦāļ™āļąāļāđāļšāļšāļŸāļīāļ™āđ† Latest News
ðŸ”Ĩ VIRAL VIDEO TRENDING RIGHT NOW 👉 WATCH HERE NOW ðŸ˜ą PEOPLE REGRET NOT WATCHING THIS EARLIER ðŸŽĨ...
Von Nuhvaj Nuhvaj 2026-07-06 23:21:23 0 945
Other
Emerging Trends in M2M Satellite Communication Market and Global Expansion Outlook
The M2M (Machine-to-Machine) Satellite Communication Solution Market is poised for significant...
Von Monica Scott 2026-06-25 13:24:45 0 1KB